AMD3100 (Plerixafor): Selectivity & Specificity
AMD3100 (Plerixafor) is a potent inhibitor of Escherichia coli S30 extract system (62.30 ±6.47mM), CXCR4 (11.4 µM), TGFβ-1 (9.1 µM). AMD3100 (Plerixafor) exhibits the greatest inhibitory potency toward TGFβ-1 (IC50 = 9100 nM).
Jump to
- AMD3100 (Plerixafor) Mechanism of Action: CXCR4 Inhibition in Immune Cell Research
- AMD3100 (Plerixafor) Clinical Trials
- AMD3100 (Plerixafor) Working Concentration | Cell Culture | Treatment
- AMD3100 (Plerixafor) Solubility in DMSO
- AMD3100 (Plerixafor) Stock Solution
- AMD3100 (Plerixafor) Storage
- AMD3100 (Plerixafor) Stability
- AMD3100 (Plerixafor) Combination Database
- AMD3100 (Plerixafor) Molecular Weight
- AMD3100 (Plerixafor) SMILES
- AMD3100 (Plerixafor) CAS Number
- AMD3100 (Plerixafor) Chemical Structure (2D and 3D)
- AMD3100 (Plerixafor) IC50 for Cell-based and Cell-free Assays
- AMD3100 (Plerixafor) Sigma (1545135)? Try a better option.
- AMD3100 (Plerixafor) MedChemExpress (HY-10046)? Try a better option.
- AMD3100 (Plerixafor) Cayman (35579)? Try a better option.
- AMD3100 (Plerixafor) APExBIO (A2025)? Try a better option.
- AMD3100 (Plerixafor) SDS｜MSDS